Katarzyna Wnuk-Lipińska

Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer

Kathleen Ludwig, Wenting Du, Noah Sorrelle et al. · Cancer Research · 2017 · 154 citations · Full text

AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells

Maria L. Lotsberg, Katarzyna Wnuk-Lipińska, Stéphane Terry et al. · Journal of Thoracic Oncology · 2020 · 89 citations · Full text

AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer

Agnete S. T. Engelsen, Katarzyna Wnuk-Lipińska, Sébastien Bougnaud et al. · iScience · 2020 · 31 citations · Full text

Abstract 1747: BGB324, a selective small molecule Axl kinase inhibitor to overcome EMT-associated drug resistance in carcinomas: Therapeutic rationale and early clinical studies

Katarzyna Wnuk-Lipińska, Crina Tiron, Gro Gausdal et al. · Cancer Research · 2014 · 15 citations

Abstract 1747, Emt-associated Drug Resistance, Cancer Biology +17

Abstract 5690: Discovery of JNJ-67856633: A novel, first-in-class MALT1 protease inhibitor for the treatment of B cell lymphomas

Ulrike Philippar, Tianbao Lu, Nele Vloemans et al. · Cancer Research · 2020 · 14 citations

Immunology, Immune Regulation, Pathology +20